TAKE ADVANTAGE OF STRENGTH TO TAKE PARTIAL PROFITS ON UNITED THERAPEUTICS, REMAINS A BUYOUT TARGET $UTHR

TAKE ADVANTAGE OF STRENGTH TO TAKE PARTIAL PROFITS ON UNITED THERAPEUTICS, REMAINS A BUYOUT TARGET $UTHRThis post was just published on ZYX Buy Change Alert.

UTHR  is long from $129.20.  It is trading at $151.47 as of this writing.  25% of the full core position size is being held. Consider taking advantage of the strength to take profits on a 10% tranche of full core position size  in the zone of $150 to $158.36.  As a reminder, if waiting for the stock to go higher before taking profits, consider raising stops for this tranche only right under the above zone.

Consider continuing to hold the remaining 15% position.  UTHR is still a buyout target. A buyout north of $200 is possible.

The plan is to buy more if it falls again.

Those not in the stock may wait for a signal on the Real Time Feed.

 

A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER

Related Posts

UPDATE ON UNITED THERAPEUTICS $UTHR

This post was just published on ZYX Buy Change Alert. UTHR has announced that it will continue the FREEDOM-EV study of Orenitram extended-release ...

A NEW IDEA ON UNITED THERAPEUTICS, BUYOUT RUMORS AT $200 $UTHR $GSK $GILD

This post was just published on ZYX Buy Change Alert. UTHR is a biotech company.  It closed at $127.92.  There are rumors that ...

Follow

Get every new post delivered to your Inbox

Join other followers